Patents by Inventor Pradeep B. Pushpavanam

Pradeep B. Pushpavanam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MCH antagonists for the treatment of obesity
    Patent number: 7345042
    Abstract: The present invention discloses methods of using antagonists for melanin-concentrating hormone (MCH), to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes, as well as novel compounds which are antagonists for melanin-concentrating hormone (MCH). In other aspects, the invention is directed to pharmaceutical compositions comprising such MCH antagonists as well as methods for preparing such compounds. Compounds of the invention generally have the structure: where the substituents are as defined herein.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: March 18, 2008
    Assignee: Schering Corporation
    Inventors: Anandan Palani, Sherry A. Shapiro, Hubert B. Josien, Thomas A. Bara, John W. Clader, Pradeep B. Pushpavanam, Shengjian Li, Mark D. McBriar
  • Aryl oxime-piperazines useful as CCR5 antagonists
    Patent number: 6689783
    Abstract: In one embodiment, this invention provides a novel class of aryl oxime-piperazine compounds as antagonists of the CCR5 receptor, methods of preparing such compounds, pharmaceutical compositions containing one or more of the compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention or amelioration of one or more of diseases associated with the CCR5 receptor.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: February 10, 2004
    Assignee: Schering Corporation
    Inventors: John W. Clader, Sue-Ing Y. Lin, Stuart W. Mc Combie, Pradeep B. Pushpavanam, Susan Vice
  • Aryl oxime-piperazines useful as CCR5 antagonists
    Publication number: 20030087912
    Abstract: In one embodiment, this invention provides a novel class of aryl oxime-piperazine compounds as antagonists of the CCR5 receptor, methods of preparing such compounds, pharmaceutical compositions containing one or more of the compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention or amelioration of one or more of diseases associated with the CCR5 receptor.
    Type: Application
    Filed: March 27, 2002
    Publication date: May 8, 2003
    Applicant: SCHERING CORPORATION
    Inventors: John W. Clader, Sue-Ing Y. Lin, Stuart W. McCombie, Pradeep B. Pushpavanam, Susan Vice